Autologous CD34+ Stem Cell Therapy Increases Coronary Flow Reserve and Reduces Angina in Patients With Coronary Microvascular Dysfunction
TD Henry, CNB Merz, J Wei et al.
KEYWORDS
microvascular angina; pilot clinical trial; therapy